Skip to content
OsmanKostekMD路 @OncologyMarwarD 路 X路路 2 days agoScore45

dostarlimab

Body 路 original

馃毃 ESMO26 | DEWI Phase II

Can surgery be avoided in dMMR/MSI-H gastric/GEJ cancer?

馃拪 Dostarlimab + watch-and-wait

馃搳 ~2/3 of 43 patients achieved 1-year cCR with organ preservation, without relapse or death.

Promising results, but longer follow-up is needed.

#ESMO26

127 views 路 2 likes 路 1 repost 路 0 replies

Conference abstracts
2877ROmatched by Rapid oral 1: Gastrointestinal tumour, upper digestive

Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study

https://esmocongress.esmo.org

Source: OsmanKostekMD 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org